Progress in the field of genetic sequencing has ushered in an era of fast and affordable sequencing, enabling the identification of the molecular underpinnings of
4bases reach new milestone in their collaboration with Oxford Nanopore to enable decentralised, flexible sequencing scalability for clinical researchers in Italy and Switzerland. 4bases, a
According to a recent study conducted by researchers from Washington, individuals in the preclinical phase of Alzheimer’s Disease (AD) exhibit a distinct gut microbiome composition
Wilmington, DE and Manno, Switzerland – One Codex, the leading provider of cloud-based microbial genomics software, is thrilled to announce a groundbreaking partnership with 4bases. This
Familial hypercholesterolemia (FH) is a genetically inherited disease characterized by high blood levels of total cholesterol and LDL cholesterol (Low-Density Lipoprotein, often referred to as
This month’s paper is interested in the genetic characteristics of two types of acute blood cancer: AML (Acute Myeloid Leukemia, most common leukemia in adults) and
In this recently published article, a multidisciplinary group from the Mayo Clinic (Rochester, Minnesota) details the discovery of a new type of thalassemia, a genetic
Thanks to modern sequencing protocols, diagnosing a genetic disease can be done in a cheap and easy way. Unfortunately, as we have seen with Cystic
Mon 20th March 2023 Oxford Nanopore’s devices with 4bases kits will enable decentralised, flexible scalability with a significant decrease in turnaround time for clinical researchers
Next Generation Sequencing (NGS) is an efficient way to keep track of disease-causing mutations in patients. Relying on this technique, a team of researchers from
Powered by Lifency SA © 2023
